Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Hypoallergenicity of a New Thickened Extensively Hydrolyzed Formula in Infants With Confirmed Cow's Milk Protein Allergy

NCT02711163 is registered in ClinicalTrials.gov with United Pharmaceuticals as lead sponsor.

NCT NCT02711163
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02711163 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Hypoallergenicity of a New Thickened Extensively Hydrolyzed Formula in Infants With Confirmed Cow's Milk Protein Allergy
Lead sponsor
United Pharmaceuticals
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2016
Completion date
November 29, 2017
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cow milk allergy